Precision Neurodegenerative Disease Global Market Report 2024-2028: Key Growth Opportunities in GLP-1 RA and Insulin for AD and PD Patients and Neurotech-based Precision Therapies
September 26, 2024 06:02 ET
|
Research and Markets
Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "Precision Neurodegenerative Disease Market, Global, 2024-2028" report has been added to ResearchAndMarkets.com's offering.The rising global...
Global Neurodegenerative Disease Market Report 2023: Sector is Expected to Reach $52.7 Billion by 2030 at a CAGR of 3.2%
May 25, 2023 12:28 ET
|
Research and Markets
Dublin, May 25, 2023 (GLOBE NEWSWIRE) -- The "Neurodegenerative Disease Market, By Indication Type, By Drug Type, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030"...
Neurodegenerative Disease Drugs Market Report (2022 to 2030) - Novartis AG, Sanofi S.A., Pfizer Inc., Biogen Inc., Merck & CO. Inc., F. Hoffman-La Roche Ltd
October 10, 2022 05:56 ET
|
Growth Plus Reports
Pune, Oct. 10, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global neurodegenerative disease drugs market is expected to clock US$ 77.01 Billion by...